Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma

HIGHLIGHTS

• who: Huahang Lin from the Medical University of Vienna, Austria have published the paper: Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma, in the Journal: (JOURNAL)
• what: Given the lack of analysis of population-based data and consensus on treatment, this study attempted to compare the efficacy of different treatment modalities on early-stage MALTtype PPL using the National Cancer Institute`s Surveillance, Epidemiology, and End Results (SEER) program database. In the study , 152 patients underwent wedge resection or segmentectomy, 300 patients underwent . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.